Reply to comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia Journal Article


Authors: Heaney, M. L.; Toy, E. L.; Vekeman, F.
Article Title: Reply to comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia
Keywords: cancer chemotherapy; treatment duration; letter; incidence; febrile neutropenia; health care cost; hospitalization; recombinant granulocyte colony stimulating factor; recombinant granulocyte macrophage colony stimulating factor
Journal Title: Cancer
Volume: 116
Issue: 12
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2010-06-15
Start Page: 3073
End Page: 3074
Language: English
DOI: 10.1002/cncr.25249
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: CANCA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark L Heaney
    94 Heaney